Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma

Hematological Oncology(2022)10.1002/hon.3098Source: DataRank Database

Cell of origin is not associated with outcomes of relapsed or refractory diffuse large B cell lymphoma is a research paper published in Hematological Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.27)OA: hybridTopics (36)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Raphael Mwangi ORCID,Alexandra N. Smith,Matthew J. Maurer ORCID,Umar Farooq ORCID,Rebecca L. King ORCID

Live enrichment

PubMed:36305717 OpenAlex:https://openalex.org/W4307498146

National Institutes of Health

Grant: 5U01CA195568-07

The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study

National Institutes of Health

Grant: 2P50CA097274-06

Biostatistics and Bioinformatics

FWCI

0.27

Citation Percentile

0.5%

Citation Trend

2022

2024

2026

hybridLicense: cc-by-nc

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.3098

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hon.3098

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3098

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/hon.3098

journalhttps://doi.org/10.1002/hon.3098

Fields of Study

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchViral-associated cancers and disorders0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Antineoplastic Combined Chemotherapy ProtocolsHumansNeoplasm Recurrence, LocalPrognosisRetrospective StudiesLymphoma, Large B-Cell, DiffuseGene Expression Profiling

Keywords

MedicineInternal medicineImmunohistochemistryLymphomaDiffuse large B-cell lymphomaCHOPRefractory (planetary science)GastroenterologyCohortBiopsyOncologyLarge cellCancerBiologyAdenocarcinomaGene Expression ProfilingAntineoplastic Combined Chemotherapy ProtocolsHumansOriginal ArticlesLymphoma, Large B-Cell, DiffuseNeoplasm Recurrence, LocalPrognosisRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being